Published within
|«
«
|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
8
|
»
»|
| Type |
Product title / description
|
Pub
|
Price |
Interactive Model
|
The expected Q4 2013 launches of Brintellix and levomilnacipran will occur against a backdrop of a declining market.
Published By Datamonitor
|
25 Apr 2013 |
$8000
|
Interactive Model
|
The hepatitis C market will experience a boom as revolutionary interferon-free regimens arrive.
Published By Datamonitor
|
17 Apr 2013 |
$8000
|
Interactive Model
|
Identify your target customer base and compare wealth markets in seconds. Our dashboard will simplify your analysis of affluent individuals and the liquid wealth they hold in a graphical and interactive interface.
Published By Datamonitor
|
08 Apr 2013 |
$40000
|
Interactive Model
|
Compare retail savings and investments markets in seconds. Our dashboard will simplify your analysis of bonds, deposits, equities, and mutual funds in a graphical and interactive interface.
Published By Datamonitor
|
04 Apr 2013 |
$40000
|
Interactive Model
|
The IBD market is set to experience considerable change over the next ten years. A number of significant new product launches will reshape the market, with sales for ulcerative colitis forecast to overtake those for Crohn's disease.
Published By Datamonitor
|
22 Mar 2013 |
$8000
|
Interactive Model
|
In the wake of Lipitor’s patent expiry, the dyslipidemia market continues to face increasing genericization leading to falling sales in key drug classes.
Published By Datamonitor
|
04 Feb 2013 |
$8000
|
Interactive Model
|
Identify your target customer base and compare their service demands, needs, and profiles in seconds. Our dashboard will simplify your analysis and improve your understanding of the different profiles of HNW individuals in 19 geographies.
Published By Datamonitor
|
18 Jan 2013 |
$10000
|
Interactive Model
|
New anti-bone loss drugs soon to reach the osteoporosis market - but generic entry will continue to erode its value.
Published By Datamonitor
|
17 Jan 2013 |
$8000
|
Interactive Model
|
There are 700,000 new cases of lung cancer each year and NSCLC constitutes about 80% of the total lung cancer patient population. Pharma have been attracted by the high incidence of this disease and the NSCLC pipeline has grown substantially.
Published By Datamonitor
|
19 Dec 2012 |
$11400
|
Interactive Model
|
An interactive tool providing direct answers to the questions which are central to developing a customer-centric strategy, the What Consumers Want series is an essential source of consumer insight at a country- and product-specific level.
Published By Datamonitor
|
20 Nov 2012 |
$5000
|
|«
«
|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
8
|
»
»|
No help is available.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Business Insight reports are an objective source of data, analysis and market insight
Insight for technology vendors into customer trends and pain points from key business decision makers.
Butler Group's thought leadership, opinion, with end user case studies and product profiles for key vendors.
Butler Group's vendor ranking and assessment model groups vendors into Outperform, Perform, and Under-perform categories.
Butler Group's thought leadership, opinion, and best practice with technology audits, product comparisons and rankings.
Opinion and market commentary from Datamonitor's industry experts.
Company profiles deliver detailed insight into how companies are organized and function with SWOT analysis.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Opinion and market commentary from Datamonitor's industry experts.
Track industry events, markets, products, customers, prospects, competitors and partners
Country profiles presenting easy-to-digest summaries and standardized data.
Databooks use charts and tables to provide a data-centric view of a particular market or category
Opinion and market commentary from Datamonitor's industry experts.
Comprehensive category data, including market value, volume, segmentation and share, with analysis.
Industry profiles provide standardized market data (including size & segmentation) and competitive analysis.
Market sizing and forecast data for a market or sector delivered in spreadsheet format.
Track industry events, markets, products, customers, prospects, competitors and partners
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Opinion and market commentary from Datamonitor's industry experts.
Insight for technology vendors into customer trends and pain points from key business decision makers.
Business information covering a specific market or issue.